Towards precision therapy in HER2-positive early-stage breast cancer

Saved in:
Bibliographic Details
Main Authors: Serena Di Cosimo, Paolo Verderio
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977625004783
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849321521650073600
author Serena Di Cosimo
Paolo Verderio
author_facet Serena Di Cosimo
Paolo Verderio
author_sort Serena Di Cosimo
collection DOAJ
format Article
id doaj-art-9c08a3dbe0c748bab3f83f96c7448f29
institution Kabale University
issn 1532-3080
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series Breast
spelling doaj-art-9c08a3dbe0c748bab3f83f96c7448f292025-08-20T03:49:44ZengElsevierBreast1532-30802025-06-018110446110.1016/j.breast.2025.104461Towards precision therapy in HER2-positive early-stage breast cancerSerena Di Cosimo0Paolo Verderio1Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Corresponding author. Via Giacomo Venezian 1, 20133 Milan, Italy.Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italyhttp://www.sciencedirect.com/science/article/pii/S0960977625004783
spellingShingle Serena Di Cosimo
Paolo Verderio
Towards precision therapy in HER2-positive early-stage breast cancer
Breast
title Towards precision therapy in HER2-positive early-stage breast cancer
title_full Towards precision therapy in HER2-positive early-stage breast cancer
title_fullStr Towards precision therapy in HER2-positive early-stage breast cancer
title_full_unstemmed Towards precision therapy in HER2-positive early-stage breast cancer
title_short Towards precision therapy in HER2-positive early-stage breast cancer
title_sort towards precision therapy in her2 positive early stage breast cancer
url http://www.sciencedirect.com/science/article/pii/S0960977625004783
work_keys_str_mv AT serenadicosimo towardsprecisiontherapyinher2positiveearlystagebreastcancer
AT paoloverderio towardsprecisiontherapyinher2positiveearlystagebreastcancer